about
P1889
Hypogammaglobulinemia with facial edema.Dysregulation of the microvasculature in nonlesional non-sun-exposed skin of patients with lupus nephritis.Granulomatous dermatitis related to silicone implant.Anti-C1q antibodies in systemic lupus erythematosus.Raynaud's phenomenon: pathogenesis and management.Rowell syndrome (systemic lupus erythematosus + erythema multiforme).Dominant Th1 and minimal Th17 skewing in discoid lupus revealed by transcriptomic comparison with psoriasis.Skin manifestations of internal disease.Topical drug-induced subacute cutaneous lupus erythematosus isolated to the hands.Extracellular generation of adenosine by the ectonucleotidases CD39 and CD73 promotes dermal fibrosis.International consensus for a definition of disease flare in lupus.Glomangioma.Livedo racemosa, secondary to drug-induced systemic lupus erythematosus.Autoimmune disease and hair loss.Hepatitis C virus and its cutaneous manifestations: treatment in the direct-acting antiviral era.Anti-MDA5 Antibody Dermatomyositis Overlap with Systemic Lupus Erythematosus: A Case Report and Review of the Literature.Dialogue: Cutaneous lupus erythematosus: a lone Wolf?Resistant discoid lupus erythematosus of palms and soles: successful treatment with azathioprine.An erythema gyratum repens variant of bullous lupus erythematosus.Targeting the ICB2 site of the topoisomerase IIalpha promoter with a formamido-pyrrole-imidazole-pyrrole H-pin polyamide.Carbohydrate metabolism in porphyria cutanea tarda.Lupus erythematosus tumidus with discoid lupus erythematosus-induced alopecia of the scalp.Morphea with discoid lupus erythematosus.Familial linear scleroderma (en coup de sabre) responsive to antimalarials and narrowband ultraviolet B therapy.Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus.Painful nodules in a young female. Antiphospholipid syndrome.Necrolytic acral erythema.Novel use of apremilast for adjunctive treatment of recalcitrant pyoderma gangrenosumAtypical mycobacteria infection in an immunocompromised patient.Secondary follicular mucinosis associated with systemic lupus erythematosus.Hypertrophic discoid lupus erythematosus.Colchicine and indomethacin for the treatment of relapsing polychondritis.Incidence of alopecia areata in lupus erythematosus.Scleredema and diabetic sclerodactyly.Delayed and recurring blisters in the donor graft site of a burn patient.A Systematic Review and Meta-Analysis of the Effects of Topical Nitrates in the Treatment of Primary and Secondary Raynaud's Phenomenon.Wood's lamp as a tool in the evaluation of morphea.Papular mucinosis, or localized lichen myxedematosis (LM) (discrete papular type).The Frisbee Maneuver: A Novel Method to Abort Acute Attacks of Raynaud's Phenomenon.Inflammatory morphea in the context of Raynaud phenomenon.
P50
Q33267827-57E123C5-BFEC-48D4-BB68-DA96F2E39BE2Q33745588-BC8322EC-6DF2-4B93-A376-C2C140E34E58Q34393985-83CAFA53-4C17-40FE-9265-5945B4389F36Q34717540-7298AF8D-D2BD-484E-B82C-8F59E396B369Q34801125-0E0C80FE-E11D-4876-B865-1DD297D22972Q35011401-77FBC7F3-B051-4828-8A9D-74AEFE957B33Q37381187-FF151B15-F302-4193-A52E-C20213701A5AQ37637039-9B8265E7-62F7-477D-8B53-A20EADCF5BE9Q37704195-7AEF6B59-EE1A-4540-90EC-1A9B916BB42EQ37716974-FB258FF5-EEF4-486B-84EC-DEF899BFD00EQ37819549-D7C89C7C-A1AC-4956-B2B2-A27372E69FE8Q37821518-A7899F13-3D82-4B1B-BB43-BBE8E4AE6559Q37821520-63D37C10-9290-4D26-86CD-14576A6397B9Q38060381-8CD1F891-F08C-4DF0-A48C-E5AED8729325Q38933599-7AAEDB7B-8653-4873-9EB9-314B9D7C7221Q39080537-E2A23780-62FA-47B7-9641-CBB3591BEEFBQ39272161-5F2D7757-E8BE-436C-9DD9-55F954D44653Q39529924-0AC2A2DE-DACC-4EA1-A00C-14A132BA07ADQ39589771-CD5F5FDE-0EAA-4794-8C2C-63F620327847Q39682624-B2A1CECE-B834-4C80-B424-B44F52CFA832Q41718999-9317A266-B19D-4C2F-B114-99F5284B1215Q41931344-FA210728-28F6-4AC5-B0E9-DED69755F757Q41931352-FEB45F1E-D5DE-49D0-98D4-02DD8E58F832Q41942983-229BE58B-F317-4EC6-8344-4A57FA02D07EQ41977234-C08F3B83-6CFB-4096-8C6D-DDA6B9194C77Q42118095-2F1F6F36-C8B0-4798-A1D9-1EAE223FF753Q42247457-C47E30E8-313D-4CC8-B6C0-C542ED55A00FQ42291222-864E7DD0-9431-4C77-B597-EBC27531FCC2Q42777286-8FCEEBBC-CE43-451A-BFEF-77EBE1388818Q42777292-046B14E9-6DB6-4EDB-A93E-7DB28E071966Q42777301-4621D136-8172-49B3-9091-13A70CD62FF2Q43864236-82FB7B79-CCEA-46C6-B386-07C04FB6778BQ44706043-BAAF960A-BFB7-4AB9-BDF1-63CBEFCB5AA8Q46887328-F8D00AB2-2DC0-4A9E-AF49-98E073BA7A2FQ47796542-5CD42C72-0599-4CF9-A13D-FC6B41113BFDQ48499935-D9851A72-A088-4956-9AC1-FE3D522CBAE3Q49380200-4C790029-D9FB-45D3-BC99-30320FBDFBC8Q49973406-CB90F7E5-833A-42BE-A6C8-FECE0F4711E0Q50091051-28E447A3-02E2-48AC-96CE-DC0A67761D3AQ50625842-F2FA5271-DEFF-4C0B-9554-D595DB6C22BD
P50
description
Clinical Professor of Dermatology and Medicine (Academic)
@en
wetenschapper
@nl
name
Andrew G Franks
@nl
Andrew G Franks
@sl
Andrew G. Franks
@en
Andrew G. Franks
@es
type
label
Andrew G Franks
@nl
Andrew G Franks
@sl
Andrew G. Franks
@en
Andrew G. Franks
@es
altLabel
Andrew G. Franks Jr MD FACP
@en
prefLabel
Andrew G Franks
@nl
Andrew G Franks
@sl
Andrew G. Franks
@en
Andrew G. Franks
@es
P106
P1153
7102725765
P1889
P21
P31
P496
0000-0001-5427-6369